Selectively Promiscuous Opioid Ligands: Discovery of High Affinity/Low Efficacy Opioid Ligands with Substantial Nociceptin Opioid Peptide Receptor Affinity

[Image: see text] Emerging clinical and preclinical evidence suggests that a compound displaying high affinity for μ, κ, and δ opioid (MOP, KOP, and DOP) receptors and antagonist activity at each, coupled with moderate affinity and efficacy at nociceptin opioid peptide (NOP) receptors will have util...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kumar, Vinod, Ridzwan, Irna E., Grivas, Konstantinos, Lewis, John W., Clark, Mary J., Meurice, Claire, Jimenez-Gomez, Corina, Pogozheva, Irina, Mosberg, Henry, Traynor, John R., Husbands, Stephen M.
Format: Artigo
Idioma:Inglês
Publicat: American Chemical Society 2014
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4033651/
https://ncbi.nlm.nih.gov/pubmed/24761755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm401964y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars